PTGER1
Basic information
Region (hg38): 19:14472466-14475354
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTGER1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 35 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 35 | 2 | 0 |
Variants in PTGER1
This is a list of pathogenic ClinVar variants found in the PTGER1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-14472600-G-C | not specified | Uncertain significance (Nov 17, 2023) | ||
19-14472604-T-C | not specified | Uncertain significance (Feb 05, 2024) | ||
19-14472640-C-T | not specified | Uncertain significance (May 24, 2023) | ||
19-14472657-C-G | not specified | Uncertain significance (Mar 29, 2023) | ||
19-14472666-G-C | not specified | Uncertain significance (Dec 06, 2021) | ||
19-14472690-C-T | not specified | Uncertain significance (Jul 05, 2022) | ||
19-14472714-A-G | not specified | Uncertain significance (Sep 27, 2022) | ||
19-14472729-T-G | not specified | Uncertain significance (Nov 30, 2022) | ||
19-14472805-C-G | not specified | Uncertain significance (May 13, 2024) | ||
19-14473395-C-T | not specified | Uncertain significance (Jun 11, 2024) | ||
19-14473470-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
19-14473530-G-A | not specified | Uncertain significance (Aug 08, 2022) | ||
19-14473596-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
19-14473605-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
19-14473608-G-T | not specified | Uncertain significance (Jul 12, 2022) | ||
19-14473612-G-C | not specified | Uncertain significance (Nov 17, 2023) | ||
19-14473621-A-T | not specified | Uncertain significance (Mar 01, 2024) | ||
19-14473711-C-T | not specified | Uncertain significance (Oct 06, 2022) | ||
19-14473732-C-A | not specified | Uncertain significance (Aug 21, 2023) | ||
19-14473741-G-T | not specified | Uncertain significance (Dec 18, 2023) | ||
19-14473788-C-A | not specified | Uncertain significance (Nov 28, 2023) | ||
19-14473840-C-G | not specified | Likely benign (Apr 07, 2023) | ||
19-14473842-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
19-14473861-C-T | not specified | Uncertain significance (May 31, 2022) | ||
19-14473869-A-C | not specified | Uncertain significance (Jul 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTGER1 | protein_coding | protein_coding | ENST00000292513 | 2 | 2897 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000973 | 0.602 | 122569 | 0 | 4 | 122573 | 0.0000163 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.746 | 141 | 168 | 0.838 | 0.0000111 | 2378 |
Missense in Polyphen | 33 | 57.658 | 0.57234 | 919 | ||
Synonymous | 0.488 | 81 | 86.8 | 0.933 | 0.00000645 | 990 |
Loss of Function | 0.517 | 5 | 6.41 | 0.780 | 3.24e-7 | 76 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000608 | 0.0000549 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000205 | 0.0000182 |
Middle Eastern | 0.0000608 | 0.0000549 |
South Asian | 0.0000374 | 0.0000329 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(q) proteins which activate a phosphatidylinositol-calcium second messenger system. May play a role as an important modulator of renal function. Implicated the smooth muscle contractile response to PGE2 in various tissues.;
- Pathway
- Calcium signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Celecoxib Pathway, Pharmacodynamics;Small Ligand GPCRs;GPCRs, Class A Rhodopsin-like;Prostaglandin Synthesis and Regulation;Signaling by GPCR;Signal Transduction;phospholipase c-epsilon pathway;ion channels and their functional role in vascular endothelium;activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor;eicosanoid metabolism;chrebp regulation by carbohydrates and camp;role of -arrestins in the activation and targeting of map kinases;activation of camp-dependent protein kinase pka;Prostanoid ligand receptors;Eicosanoid ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);roles of arrestin dependent recruitment of src kinases in gpcr signaling;GPCR ligand binding;-arrestins in gpcr desensitization;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.0196
- hipred
- N
- hipred_score
- 0.459
- ghis
- 0.470
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.158
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptger1
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); neoplasm; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype;
Gene ontology
- Biological process
- inflammatory response;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;adenylate cyclase-activating dopamine receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;response to lipopolysaccharide;negative regulation of gastric emptying
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- prostaglandin E receptor activity;D1 dopamine receptor binding